| Time slot | Speaker | Topic | Location |
| 08.00-09.00 | Peter Tonge | The Role of Drug-Target Kinetics in Drug Discovery | auditorium |
| 09.00-10.00 | Chun Wa Chung | Getting biophysical-understanding MMOAs to help us find better drugs faster | auditorium |
| 10.00-10.30 | Coffee break | ||
| 10.30-11.30 | Gregg Siegal | Application of Biophysics in Modern Drug Discovery: Fragments to Structure | auditorium |
| 11.30-12.30 | Jonathan Mason | GPCR Drug Design: A torrent of new approaches makes full structure-based drug design a reality, from fragment-based lead gene-ration through the key role of waters to the prediction of binding affinity | auditorium |
| 12.30-14.00 | Lunch | ||
| 14.00-15.00 | Alex Hird | Discovery and Synthesis of a Series of Macrocyclic Indole Acids as Inhibitors of Mcl-1 | auditorium |
| 15.00-16.00 | Nick Meanwell | The Discovery of HCV NS5A Replication Complex Inhibitors Leading to Daclatasvir | auditorium |
| 16.30-17.30 | Bus ride to Bex | ||
| 18.00-20.00 | Visit of the salt mines | ||
| 20.00-22.00 | Dinner underground | ||
| 22.30-23.30 | Bus ride back to Leysin | ||









